Some notable statistically significant differences were a relative decrease in naive T cells (both CD4+ and CD8+) in progressive patients, as well as an increase in plasmablasts and dividing T & NK cells in COVID-19 patients vs controls. This evidence concerns the gene CD8A and COVID-19.